文献速递结核与非结核分枝杆菌艾滋病与性传播感染

免疫功能受损儿童和青少年的结核病:儿科结核病网络欧洲试验组多中心病例对照研究

Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study.
PubMed 文献 · Clin Infect Dis · 2024-01-01

该多中心匹配病例对照研究纳入2000-2020年诊断的417例18岁以下结核病病例,其中139例免疫功能受损(IC)患儿与278例非IC对照比较。IC患儿非呼吸道结核、重症疾病及长期后遗症比例均更高,结核菌素皮肤试验和QuantiFERON-TB Gold假阴性率更高,微生物学确诊率两组相似。

要点

  • IC患儿非呼吸道结核比例为32.4%,高于对照的21.2%(P = .013)。
  • IC患儿重症疾病比例为57.6%,高于对照的38.5%(P < .001;OR 2.073,95%CI 1.37-3.13)。
  • IC患儿结核菌素皮肤试验假阴性率31.9% vs 对照6.0%(P < .001),QuantiFERON-TB Gold假阴性率30.0% vs 7.3%(P < .001)。

核心结论

  • 欧洲IC结核病患儿非呼吸道结核、重症疾病和长期后遗症发生率增高,免疫学结核试验敏感性差;未来研究应聚焦开发在IC患者中表现更好的免疫学结核试验并确定长期后遗症风险增高的原因,以设计预防性管理策略。

研究设计与样本

  • 儿科结核病网络欧洲试验组内开展的多中心匹配病例对照研究,纳入2000-2020年诊断的18岁以下结核病病例。
  • 共纳入417例结核病病例,包括139例IC患儿(人类免疫缺陷病毒、先天性免疫缺陷、药物诱导免疫抑制及其他免疫受损状况)和278例非IC对照儿童。

主要发现

  • 非呼吸道结核在病例组比对照组更常见(32.4% vs 21.2%;P = .013)。
  • IC患者发生重症疾病的可能性增加(57.6% vs 38.5%;P < .001;OR 2.073,95%CI 1.37-3.13)。
  • IC患儿诊断时结核菌素皮肤试验假阴性率更高(31.9% vs 6.0%;P < .001),QuantiFERON-TB Gold试验假阴性率更高(30.0% vs 7.3%;P < .001)。
  • 微生物学确诊率在IC与非IC病例中相似(58.3% vs 49.3%;P = .083)。
  • IC患儿死亡率<1%,但长期后遗症发生率显著高于非IC病例(14.8% vs 6.1%;P = .004)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In high-resource settings, the survival of children with immunocompromise (IC) has increased and immunosuppressive therapies are increasingly being used. This study aimed to determine the clinical characteristics, performance of diagnostic tools, and outcome of IC children with tuberculosis (TB) in Europe. METHODS: Multicenter, matched case-control study within the Pediatric Tuberculosis Network European Trials Group, capturing TB cases <18 years diagnosed 2000-2020. RESULTS: A total of 417 TB cases were included, comprising 139 children who are IC (human immunodeficiency virus, inborn errors of immunity, drug-induced immunosuppression, and other immunocompromising conditions) and 278 non-IC children as controls. Nonrespiratory TB was more frequent among cases than controls (32.4% vs 21.2%; P = .013). Patients with IC had an increased likelihood of presenting with severe disease (57.6% vs 38.5%; P < .001; odds ratio [95% confidence interval], 2.073 [1.37-3.13]). Children with IC had higher rates of false-negative tuberculin skin test (31.9% vs 6.0%; P < .001) and QuantiFERON-TB Gold assay (30.0% vs 7.3%; P < .001) results at diagnosis. Overall, the microbiological confirmation rate was similar in IC and non-IC cases (58.3% vs 49.3%; P = .083). Although the mortality in children with IC was <1%, the rate of long-term sequelae was significantly higher than in non-IC cases (14.8% vs 6.1%; P = .004). CONCLUSIONS: Children with IC and TB in Europe have increased rates of nonrespiratory TB, severe disease, and long-term sequelae. Immune-based TB tests have poor sensitivity in those children. Future research should focus on developing improved immunological TB tests that perform better in patients with IC, and determining the reasons for the increased risk of long-term sequelae, with the aim to design preventive management strategies.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Rodríguez-Molino P, Tebruegge M, Noguera-Julian A, et al. Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study. Clin Infect Dis. 2024. PMID: 38568992. doi:10.1093/cid/ciae158

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。